Biogen Inc. Stock Rallies 3.4%, Outperforms Peers

Dow Jones04-21

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Biogen Inc. rallied 3.4% to $183.34 on what proved to be an all-around rough trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 49,442.56 and the S&P 500 Index falling 0.2% to 7,109.14.

This was the stock's second consecutive day of gains.

Biogen Inc. closed 9.4% below its 52-week high of $202.41, which the company reached on February 6th.

The stock outperformed some of its peers, as Johnson & Johnson fell 1.5% to $230.69, Pfizer Inc. fell 0.1% to $27.52, and AbbVie Inc. fell 2.24% to $203.71.

Trading volume totaled 1.5 million, compared to the 50-day average of 1.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

April 20, 2026 16:35 ET (20:35 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2629776236?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-21 04:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2629776236","market":"us","top_or_hot":-1,"title":"Biogen Inc. Stock Rallies 3.4%, Outperforms Peers","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Biogen Inc. rallied 3.4% to $183.34 on what proved to be an all-around rough trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 49,442.56 and the S&amp;P 500 Index falling 0.2% to 7,109.14. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Biogen Inc. closed 9.4% below its 52-week high of $202.41, which the company reached on February 6th. \n</p>\n<p>\n     The stock outperformed some of its peers, as Johnson &amp; Johnson fell 1.5% to $230.69, Pfizer Inc. fell 0.1% to $27.52, and AbbVie Inc. fell 2.24% to $203.71. \n</p>\n<p>\n     Trading volume totaled 1.5 million, compared to the 50-day average of 1.2 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 20, 2026 16:35 ET (20:35 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Inc. Stock Rallies 3.4%, Outperforms Peers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Inc. Stock Rallies 3.4%, Outperforms Peers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-04-21 04:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Biogen Inc. rallied 3.4% to $183.34 on what proved to be an all-around rough trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 49,442.56 and the S&amp;P 500 Index falling 0.2% to 7,109.14. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Biogen Inc. closed 9.4% below its 52-week high of $202.41, which the company reached on February 6th. \n</p>\n<p>\n     The stock outperformed some of its peers, as Johnson &amp; Johnson fell 1.5% to $230.69, Pfizer Inc. fell 0.1% to $27.52, and AbbVie Inc. fell 2.24% to $203.71. \n</p>\n<p>\n     Trading volume totaled 1.5 million, compared to the 50-day average of 1.2 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 20, 2026 16:35 ET (20:35 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BIIB","symbol_name":"渤健公司","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2629776236","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2629776236","pubTimestamp":1776717300,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Biogen Inc. rallied 3.4% to $183.34 on what proved to be an all-around rough trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 49,442.56 and the S&P 500 Index falling 0.2% to 7,109.14.This was the stock's second consecutive day of gains.Biogen Inc. closed 9.4% below its 52-week high of $202.41, which the company reached on February 6th.The stock outperformed some of its peers, as Johnson & Johnson fell 1.5% to $230.69, Pfizer Inc. fell 0.1% to $27.52, and AbbVie Inc. fell 2.24% to $203.71.Trading volume totaled 1.5 million, compared to the 50-day average of 1.2 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"BIIB":"渤健公司"},"translate_title":"Biogen Inc.股价上涨3.4%，跑赢同行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIIB":1.5},"content_text":"This article was automatically generated by Dow Jones using technology from Automated Insights. \n\n\n     Shares of Biogen Inc. rallied 3.4% to $183.34 on what proved to be an all-around rough trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 49,442.56 and the S&P 500 Index falling 0.2% to 7,109.14. \n\n\n     This was the stock's second consecutive day of gains. \n\n\n     Biogen Inc. closed 9.4% below its 52-week high of $202.41, which the company reached on February 6th. \n\n\n     The stock outperformed some of its peers, as Johnson & Johnson fell 1.5% to $230.69, Pfizer Inc. fell 0.1% to $27.52, and AbbVie Inc. fell 2.24% to $203.71. \n\n\n     Trading volume totaled 1.5 million, compared to the 50-day average of 1.2 million. \n\n\n  Data source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 20, 2026 16:35 ET (20:35 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2629776236","isCrawlerRequest":true}